Review



anti total smad 2 3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Cell Signaling Technology Inc anti total smad 2 3
    Anti Total Smad 2 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 5691 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti total smad 2 3/product/Cell Signaling Technology Inc
    Average 98 stars, based on 5691 article reviews
    anti total smad 2 3 - by Bioz Stars, 2026-03
    98/100 stars

    Images



    Similar Products

    98
    Cell Signaling Technology Inc anti total smad 2 3
    Anti Total Smad 2 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti total smad 2 3/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    anti total smad 2 3 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc centrifugation
    Centrifugation, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/centrifugation/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    centrifugation - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc gfap 1
    Gfap 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap 1/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    gfap 1 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cell lysis buffer
    Cell Lysis Buffer, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lysis buffer/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    cell lysis buffer - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against total smad2/3
    NETs promote EMT in gastric cancer cells. (A) Transwell invasion assay and wound healing assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images at 48 h were shown. (B) Western blot analysis of EMT <t>markers</t> <t>(PAI‐1,</t> <t>Vimentin,</t> N‐cadherin, E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs. Scale bar: 20 μm. (C) Sphere formation assay and CCK‐8 proliferation assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images of sphere formation assay at 48 h were shown.
    Primary Antibodies Against Total Smad2/3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against total smad2/3/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against total smad2/3 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc protein targets
    NETs promote EMT in gastric cancer cells. (A) Transwell invasion assay and wound healing assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images at 48 h were shown. (B) Western blot analysis of EMT <t>markers</t> <t>(PAI‐1,</t> <t>Vimentin,</t> N‐cadherin, E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs. Scale bar: 20 μm. (C) Sphere formation assay and CCK‐8 proliferation assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images of sphere formation assay at 48 h were shown.
    Protein Targets, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein targets/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    protein targets - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc p smad2
    NETs promote EMT in gastric cancer cells. (A) Transwell invasion assay and wound healing assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images at 48 h were shown. (B) Western blot analysis of EMT <t>markers</t> <t>(PAI‐1,</t> <t>Vimentin,</t> N‐cadherin, E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs. Scale bar: 20 μm. (C) Sphere formation assay and CCK‐8 proliferation assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images of sphere formation assay at 48 h were shown.
    P Smad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p smad2/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    p smad2 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc rabbit anti human total smad2 3
    List of primary and secondary antibodies used for immunohistochemistry (IHC), tyramide signal amplification (TSA), co-immunofluorescence (Co-IF) and Western blotting (WB).
    Rabbit Anti Human Total Smad2 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human total smad2 3/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    rabbit anti human total smad2 3 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc smad2
    KO or inhibition of DHPS attenuated the TGFβ signaling pathway in OC cells. a , b . Western blot analysis showing the expression of phospho- and total <t>SMAD2</t> in DHPS knockout (KO) and control SKOV3 and OVCAR8 cells following treatment with 6 ng/ml TGFβ at the indicated time points. c , d . Western blot analysis showing the expression of phospho- and total SMAD2 in SKOV3 and OVCAR8 cells following treatment with 20 µM GC7 for 12 h and subsequent treatment with 6 ng/ml TGFβ at the indicated time points.
    Smad2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/smad2/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    smad2 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc horse radish peroxidase
    KO or inhibition of DHPS attenuated the TGFβ signaling pathway in OC cells. a , b . Western blot analysis showing the expression of phospho- and total <t>SMAD2</t> in DHPS knockout (KO) and control SKOV3 and OVCAR8 cells following treatment with 6 ng/ml TGFβ at the indicated time points. c , d . Western blot analysis showing the expression of phospho- and total SMAD2 in SKOV3 and OVCAR8 cells following treatment with 20 µM GC7 for 12 h and subsequent treatment with 6 ng/ml TGFβ at the indicated time points.
    Horse Radish Peroxidase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/horse radish peroxidase/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    horse radish peroxidase - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    NETs promote EMT in gastric cancer cells. (A) Transwell invasion assay and wound healing assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images at 48 h were shown. (B) Western blot analysis of EMT markers (PAI‐1, Vimentin, N‐cadherin, E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs. Scale bar: 20 μm. (C) Sphere formation assay and CCK‐8 proliferation assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images of sphere formation assay at 48 h were shown.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Molecular Mechanisms of Neutrophil Extracellular Traps in Promoting Gastric Cancer Epithelial–Mesenchymal Transition Through SERPINE‐1 Expression

    doi: 10.1002/jbt.70157

    Figure Lengend Snippet: NETs promote EMT in gastric cancer cells. (A) Transwell invasion assay and wound healing assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images at 48 h were shown. (B) Western blot analysis of EMT markers (PAI‐1, Vimentin, N‐cadherin, E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in HGC‐27 and MKN‐45 cells treated with NETs. Scale bar: 20 μm. (C) Sphere formation assay and CCK‐8 proliferation assay of HGC‐27 and MKN‐45 cells treated with NETs or DNase‐1‐treated NETs. Representative images of sphere formation assay at 48 h were shown.

    Article Snippet: The membranes were blocked with 5% non‐fat milk and then incubated with primary antibodies against PAI‐1, Vimentin, N‐cadherin, E‐cadherin, TGF‐β1, TGF‐βR1, TGF‐βR2, phospho‐Smad2/3, Smad4 and total Smad2/3 (all 1:1,000, Cell Signaling Technology) overnight at 4°C.

    Techniques: Transwell Invasion Assay, Wound Healing Assay, Western Blot, Immunofluorescence, Staining, Tube Formation Assay, CCK-8 Assay, Proliferation Assay

    SERPINE‐1 knockdown reverses NET‐induced EMT in gastric cancer cells. (A) Western blot analysis confirming SERPINE‐1 knockdown efficiency in HGC‐27 and MKN‐45 cells. (B) Western blot analysis of EMT markers in control and SERPINE‐1 knockdown cells treated with NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in control and SERPINE‐1 knockdown cells treated with NETs. Scale bar: 20 μm. (C) Transwell invasion assay and wound healing assay of control and SERPINE‐1 knockdown cells treated with NETs. Representative images at 48 h were shown. (D) CCK‐8 proliferation assay of control and SERPINE‐1 knockdown cells treated with NETs.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Molecular Mechanisms of Neutrophil Extracellular Traps in Promoting Gastric Cancer Epithelial–Mesenchymal Transition Through SERPINE‐1 Expression

    doi: 10.1002/jbt.70157

    Figure Lengend Snippet: SERPINE‐1 knockdown reverses NET‐induced EMT in gastric cancer cells. (A) Western blot analysis confirming SERPINE‐1 knockdown efficiency in HGC‐27 and MKN‐45 cells. (B) Western blot analysis of EMT markers in control and SERPINE‐1 knockdown cells treated with NETs. Additionally, immunofluorescence co‐staining of PAI‐1 and EMT typical markers (Vimentin, N‐cadherin, and E‐cadherin) in control and SERPINE‐1 knockdown cells treated with NETs. Scale bar: 20 μm. (C) Transwell invasion assay and wound healing assay of control and SERPINE‐1 knockdown cells treated with NETs. Representative images at 48 h were shown. (D) CCK‐8 proliferation assay of control and SERPINE‐1 knockdown cells treated with NETs.

    Article Snippet: The membranes were blocked with 5% non‐fat milk and then incubated with primary antibodies against PAI‐1, Vimentin, N‐cadherin, E‐cadherin, TGF‐β1, TGF‐βR1, TGF‐βR2, phospho‐Smad2/3, Smad4 and total Smad2/3 (all 1:1,000, Cell Signaling Technology) overnight at 4°C.

    Techniques: Knockdown, Western Blot, Control, Immunofluorescence, Staining, Transwell Invasion Assay, Wound Healing Assay, CCK-8 Assay, Proliferation Assay

    List of primary and secondary antibodies used for immunohistochemistry (IHC), tyramide signal amplification (TSA), co-immunofluorescence (Co-IF) and Western blotting (WB).

    Journal: Frontiers in Immunology

    Article Title: Potential implications of granzyme B in keloids and hypertrophic scars through extracellular matrix remodeling and latent TGF-β activation

    doi: 10.3389/fimmu.2024.1484462

    Figure Lengend Snippet: List of primary and secondary antibodies used for immunohistochemistry (IHC), tyramide signal amplification (TSA), co-immunofluorescence (Co-IF) and Western blotting (WB).

    Article Snippet: WB , Rabbit anti-human total smad2/3 , , Cell signaling (mAb#3102) , 1/500 in TBS-0.1% Tween + 5% milk , HRP-conjugated goat anti-rabbit , 1/2,500 in TBS-0.1% Tween, 10% milk.

    Techniques: Immunohistochemistry, Amplification, Western Blot, Blocking Assay

    KO or inhibition of DHPS attenuated the TGFβ signaling pathway in OC cells. a , b . Western blot analysis showing the expression of phospho- and total SMAD2 in DHPS knockout (KO) and control SKOV3 and OVCAR8 cells following treatment with 6 ng/ml TGFβ at the indicated time points. c , d . Western blot analysis showing the expression of phospho- and total SMAD2 in SKOV3 and OVCAR8 cells following treatment with 20 µM GC7 for 12 h and subsequent treatment with 6 ng/ml TGFβ at the indicated time points.

    Journal: Scientific Reports

    Article Title: Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway

    doi: 10.1038/s41598-025-85466-5

    Figure Lengend Snippet: KO or inhibition of DHPS attenuated the TGFβ signaling pathway in OC cells. a , b . Western blot analysis showing the expression of phospho- and total SMAD2 in DHPS knockout (KO) and control SKOV3 and OVCAR8 cells following treatment with 6 ng/ml TGFβ at the indicated time points. c , d . Western blot analysis showing the expression of phospho- and total SMAD2 in SKOV3 and OVCAR8 cells following treatment with 20 µM GC7 for 12 h and subsequent treatment with 6 ng/ml TGFβ at the indicated time points.

    Article Snippet: The membranes were then blocked with 5% nonfat milk for 1 h and incubated with primary antibodies against the following proteins: DHPS (Novus), Hypusine (Millipore Sigma), EIF5A2, Cytokeratin-7 (Abcam), GAPDH (Santa Cruz; St. Louis, MO), Vimentin, E-cadherin, β-catenin, total-Smad2, or p-Smad2 (Cell Signaling).

    Techniques: Inhibition, Western Blot, Expressing, Knock-Out, Control

    KO or inhibition of DHPS using lentiviral CRISPR/Cas9 nickase vector suppressed primary ovarian tumor growth and metastasis in orthotopic OC mouse model. ( a ) Primary ovarian tumors dissected one month after intrabursal injection of DHPS KO and control OVCAR8 cells. Tumor weight in DHPS KO is significantly lower than in the control group ( n = 5, ** P < 0.01). ( b ) Bioluminescence imaging of metastatic tumors in the liver of mice xenografted with DHPS KO and control cells ( n = 3, ** P < 0.01). ( c ) Histopathological characterization of metastatic tumors from the liver of mice xenografted with DHPS KO and control cells using H&E staining. ( d ) Western blot analysis of DHPS, Hypusine, EIF5A2, p-SMAD2, and EMT markers in primary tumors of mice xenografted with DHPS KO and control cells. ( e ) Significant reduction in primary ovarian tumor weight in mice treated with GC7 compared to control (*** P < 0.001). ( f ) Bioluminescence imaging of metastatic tumors in the liver of mice xenografted with GC7 treatment and the control group (*** P < 0.001). ( g ) Histopathological characterization of metastatic tumors from the liver of mice xenografted with GC7 treatment and the control group using H&E staining. ( h ) Western blot analysis of DHPS, EIF5A2, p-SMAD2, and EMT markers in primary tumors of mice treated with GC7 and the control group (** P < 0.01; *** P < 0.001).

    Journal: Scientific Reports

    Article Title: Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway

    doi: 10.1038/s41598-025-85466-5

    Figure Lengend Snippet: KO or inhibition of DHPS using lentiviral CRISPR/Cas9 nickase vector suppressed primary ovarian tumor growth and metastasis in orthotopic OC mouse model. ( a ) Primary ovarian tumors dissected one month after intrabursal injection of DHPS KO and control OVCAR8 cells. Tumor weight in DHPS KO is significantly lower than in the control group ( n = 5, ** P < 0.01). ( b ) Bioluminescence imaging of metastatic tumors in the liver of mice xenografted with DHPS KO and control cells ( n = 3, ** P < 0.01). ( c ) Histopathological characterization of metastatic tumors from the liver of mice xenografted with DHPS KO and control cells using H&E staining. ( d ) Western blot analysis of DHPS, Hypusine, EIF5A2, p-SMAD2, and EMT markers in primary tumors of mice xenografted with DHPS KO and control cells. ( e ) Significant reduction in primary ovarian tumor weight in mice treated with GC7 compared to control (*** P < 0.001). ( f ) Bioluminescence imaging of metastatic tumors in the liver of mice xenografted with GC7 treatment and the control group (*** P < 0.001). ( g ) Histopathological characterization of metastatic tumors from the liver of mice xenografted with GC7 treatment and the control group using H&E staining. ( h ) Western blot analysis of DHPS, EIF5A2, p-SMAD2, and EMT markers in primary tumors of mice treated with GC7 and the control group (** P < 0.01; *** P < 0.001).

    Article Snippet: The membranes were then blocked with 5% nonfat milk for 1 h and incubated with primary antibodies against the following proteins: DHPS (Novus), Hypusine (Millipore Sigma), EIF5A2, Cytokeratin-7 (Abcam), GAPDH (Santa Cruz; St. Louis, MO), Vimentin, E-cadherin, β-catenin, total-Smad2, or p-Smad2 (Cell Signaling).

    Techniques: Inhibition, CRISPR, Plasmid Preparation, Injection, Control, Imaging, Staining, Western Blot